These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 789414)

  • 61. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB; Beeuwkes R
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [DDAVP in the treatment of hypophyseal diabetes, nocturnal enuresis and in rapid determination of the concentrating function of the kidney].
    Likhardus V; Nemetova V; Legotska V
    Sov Med; 1976 Oct; (10):106-9. PubMed ID: 1023360
    [No Abstract]   [Full Text] [Related]  

  • 63. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM
    Obstet Gynecol; 1986 Aug; 68(2):288-9. PubMed ID: 3737046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improved psychological status of children under DDAVP therapy for central diabetes insipidus.
    Waggoner RW; Slonim AE; Armstrong SH
    Am J Psychiatry; 1978 Mar; 135(3):361-2. PubMed ID: 626231
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].
    Gelli D; Riolo A; Carioni E; Albano M
    Minerva Endocrinol; 1989; 14(4):227-32. PubMed ID: 2636699
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
    Vandergheynst F; Decaux G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of 1-deamino-5-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone).
    Rado JP; Juhos E
    J Clin Pharmacol; 1976 Jul; 16(7):333-7. PubMed ID: 985828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
    Flachsbarth F; Wilhelms E
    MMW Munch Med Wochenschr; 1982 May; 124(19):485-6. PubMed ID: 6810116
    [No Abstract]   [Full Text] [Related]  

  • 70. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DDAVP modified water-deprivation test in diagnosis of diabetes insipidus in a vasopressin-sensitive patient.
    Warner BA; Trautlein JJ; Caputo G; Manni A
    J Am Osteopath Assoc; 1984 Aug; 83(12):857-8. PubMed ID: 6237079
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Letter: Response to vasopressin analogues in diabetes insipidus.
    N Engl J Med; 1976 Aug; 295(7):393-4. PubMed ID: 778620
    [No Abstract]   [Full Text] [Related]  

  • 75. Desmopressin for diabetes insipidus.
    Med Lett Drugs Ther; 1978 Mar; 20(5):26-7. PubMed ID: 628371
    [No Abstract]   [Full Text] [Related]  

  • 76. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JR; Szende L; Marosi J
    Metabolism; 1974 Nov; 23(11):1057-63. PubMed ID: 4214480
    [No Abstract]   [Full Text] [Related]  

  • 78. Diabetes insipidus treated by DDAVP.
    Short JR; Isles A
    Med J Aust; 1976 May; 1(20):756-7. PubMed ID: 958068
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
    Nakakura M; Terajima M; Kato Y; Hayakawa E; Ito K; Kuroda T
    J Drug Target; 1995; 2(6):487-92. PubMed ID: 7773610
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.